Global Stress/Anxiety Treatment for Dogs & Cats Market

Stress/Anxiety Treatment for Dogs & Cats Comprehensive Study by Sales Channel (Offline (Vets, Retail), Online), Medication (Product Category, - Drug (Diazepam, Sileo, Clomicalm, fluoxetine, Paroxetine, Sertraline other), - Calming Supplement, - Product (Diffusers, Collars, and Humidifier), Category, - Prescribe base, - OTC, Nature, - Branded, - Generics, Compound, - Nutraceuticals, - Pharmaceutical, - Bio Pharmaceutical), End User (Cats, Dogs) Players and Region - Global Market Outlook to 2028

Stress/Anxiety Treatment for Dogs & Cats Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Market Snapshot:
The global Stress/Anxiety Treatment for Dogs & Cats market is expected to witness high demand in the forecasted period due to the rising number of stress anxiety cases in the dog and cat in the pandemic period. Dogs and cats, like people, suffer from anxiety. It is a normal and healthy emotion, despite the fact that it is unpleasant. Dog anxiety affects all breeds, yet it differs from one dog to the next. Although all dogs experience anxiety from time to time, if excessive levels of worry are not addressed, a dog might develop an anxiety disorder. Dog anxiety, if left untreated, can develop into behavioral and other problems. Whale eye (when dogs display the whites of their eyes), tucked ears, tucked tail, increased hackles, lip-licking, yawning, and panting are all stress symptoms to look for. Your dog may also glance away or avoid eye contact.

Highlights from Stress/Anxiety Treatment for Dogs & Cats Market Study
AttributesDetails
Study Period2018-2028
Base Year2022
Largest MarketNorth America
UnitValue (USD Million)


The key Players profiled in the report are Vétoquinol S.A (France), SeQuent Scientific Ltd. (India), Ceva Santé Animale (France), Elanco Animal Health (United States), Merck & Co., Inc (United States), Nutreco N.V. (Netherlands), Sanofi S.A (France), Zoetis Inc. (United States), IDVet (France) and Cargill, Inc. (United States). Additionally, other players that are part of this comprehensive study are Virbac (France), DSM N.V (Netherlands), Eli Lilly and Company (United States), IDEXX Laboratories, Inc. (United States) and Canopy Growth (Canada).

Geographic Breakdown and Segment Analysis
The Global Stress/Anxiety Treatment for Dogs & Cats market presents a comprehensive analysis of the Stress/Anxiety Treatment for Dogs & Cats market and by geography (North America, South America, Europe, Asia-Pacific and MEA) along with country level break-up. This section of our report presents a realistic picture of the Global Stress/Anxiety Treatment for Dogs & Cats industry. Investors and Players can easily understand the inherent opportunities and challenges for their products in geographical region of interest. For instance, while the North America holds majority of market share of the Stress/Anxiety Treatment for Dogs & Cats market, the Europe has emerged as a crucial market for several Stress/Anxiety Treatment for Dogs & Cats brands.

Analyst at AMA have segmented the market study of Global Stress/Anxiety Treatment for Dogs & Cats market by Type, Application and Region.

Influencing Trend:
The Growing Trend of Pet Care Medication across the World

Market Growth Drivers:
Increasing Popularity of the Dog and Cats and The Surging Cases of Stress/Anxiety Treatment in the Dogs & Cats

Challenges:
The Negative Impact of the COVID 19

Restraints:
The Concern related to Limited Number of Approved Drugs in Some Services

Opportunities:
The Rising Number of R & D in the Field of Pet Care Medicine and The increase in veterinarian expenses is that medical technology has progressed

Market Developments Activities:
on 17th January 2020 IDEXX Laboratories, Inc., a global leader in veterinary diagnostics and software, today announced that it is launching a new rapid digital cytology service that digitally connects veterinarians to the largest global network of more than 100 veterinary clinical pathologists and enables them to receive cytology interpretations within 2 hours.
On 4th May 2021, Veterinarians in the U.S. now have a new, innovative option for flea and tick control as Elanco Animal Health Incorporated introduces Credelio Cat, the first oral flea and tick product for cats.



Acquisitions, collaborations, expansions, product releases, and strengthening existing distribution networks are all being used by market participants in the canine separation anxiety therapy space to grow their regional presence.

Key Target Audience
Stress/Anxiety Treatment for Dogs & Cats Providers, Government Regulatory Bodies, Private Research Organization, Government Research Organizations and Others

Report Objectives / Segmentation Covered

By Sales Channel
  • Offline (Vets, Retail)
  • Online

By Medication
  • Product Category
  • - Drug (Diazepam, Sileo, Clomicalm, fluoxetine, Paroxetine, Sertraline other)
  • - Calming Supplement
  • - Product (Diffusers, Collars, and Humidifier)
  • Category
  • - Prescribe base
  • - OTC
  • Nature
  • - Branded
  • - Generics
  • Compound
  • - Nutraceuticals
  • - Pharmaceutical
  • - Bio Pharmaceutical

By End User
  • Cats
  • Dogs

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Popularity of the Dog and Cats
      • 3.2.2. The Surging Cases of Stress/Anxiety Treatment in the Dogs & Cats
    • 3.3. Market Challenges
      • 3.3.1. The Negative Impact of the COVID 19
    • 3.4. Market Trends
      • 3.4.1. The Growing Trend of Pet Care Medication across the World
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Stress/Anxiety Treatment for Dogs & Cats, by Sales Channel, Medication, End User and Region (value and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Stress/Anxiety Treatment for Dogs & Cats (Value)
      • 5.2.1. Global Stress/Anxiety Treatment for Dogs & Cats by: Sales Channel (Value)
        • 5.2.1.1. Offline (Vets, Retail)
        • 5.2.1.2. Online
      • 5.2.2. Global Stress/Anxiety Treatment for Dogs & Cats by: Medication (Value)
        • 5.2.2.1. Product Category
        • 5.2.2.2. - Drug (Diazepam, Sileo, Clomicalm, fluoxetine, Paroxetine, Sertraline other)
        • 5.2.2.3. - Calming Supplement
        • 5.2.2.4. - Product (Diffusers, Collars, and Humidifier)
        • 5.2.2.5. Category
        • 5.2.2.6. - Prescribe base
        • 5.2.2.7. - OTC
        • 5.2.2.8. Nature
        • 5.2.2.9. - Branded
        • 5.2.2.10. - Generics
        • 5.2.2.11. Compound
        • 5.2.2.12. - Nutraceuticals
        • 5.2.2.13. - Pharmaceutical
        • 5.2.2.14. - Bio Pharmaceutical
      • 5.2.3. Global Stress/Anxiety Treatment for Dogs & Cats by: End User (Value)
        • 5.2.3.1. Cats
        • 5.2.3.2. Dogs
      • 5.2.4. Global Stress/Anxiety Treatment for Dogs & Cats Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Stress/Anxiety Treatment for Dogs & Cats (Price)
  • 6. Stress/Anxiety Treatment for Dogs & Cats: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Vétoquinol S.A (France)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. SeQuent Scientific Ltd. (India)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Ceva Santé Animale (France)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Elanco Animal Health (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Merck & Co., Inc (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Nutreco N.V. (Netherlands)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Sanofi S.A (France)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Zoetis Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. IDVet (France)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Cargill, Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Stress/Anxiety Treatment for Dogs & Cats Sale, by Sales Channel, Medication, End User and Region (value and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Stress/Anxiety Treatment for Dogs & Cats (Value)
      • 7.2.1. Global Stress/Anxiety Treatment for Dogs & Cats by: Sales Channel (Value)
        • 7.2.1.1. Offline (Vets, Retail)
        • 7.2.1.2. Online
      • 7.2.2. Global Stress/Anxiety Treatment for Dogs & Cats by: Medication (Value)
        • 7.2.2.1. Product Category
        • 7.2.2.2. - Drug (Diazepam, Sileo, Clomicalm, fluoxetine, Paroxetine, Sertraline other)
        • 7.2.2.3. - Calming Supplement
        • 7.2.2.4. - Product (Diffusers, Collars, and Humidifier)
        • 7.2.2.5. Category
        • 7.2.2.6. - Prescribe base
        • 7.2.2.7. - OTC
        • 7.2.2.8. Nature
        • 7.2.2.9. - Branded
        • 7.2.2.10. - Generics
        • 7.2.2.11. Compound
        • 7.2.2.12. - Nutraceuticals
        • 7.2.2.13. - Pharmaceutical
        • 7.2.2.14. - Bio Pharmaceutical
      • 7.2.3. Global Stress/Anxiety Treatment for Dogs & Cats by: End User (Value)
        • 7.2.3.1. Cats
        • 7.2.3.2. Dogs
      • 7.2.4. Global Stress/Anxiety Treatment for Dogs & Cats Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Stress/Anxiety Treatment for Dogs & Cats (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Stress/Anxiety Treatment for Dogs & Cats: by Sales Channel(USD Million)
  • Table 2. Stress/Anxiety Treatment for Dogs & Cats Offline (Vets, Retail) , by Region USD Million (2017-2022)
  • Table 3. Stress/Anxiety Treatment for Dogs & Cats Online , by Region USD Million (2017-2022)
  • Table 4. Stress/Anxiety Treatment for Dogs & Cats: by Medication(USD Million)
  • Table 5. Stress/Anxiety Treatment for Dogs & Cats Product Category , by Region USD Million (2017-2022)
  • Table 6. Stress/Anxiety Treatment for Dogs & Cats - Drug (Diazepam, Sileo, Clomicalm, fluoxetine, Paroxetine, Sertraline other) , by Region USD Million (2017-2022)
  • Table 7. Stress/Anxiety Treatment for Dogs & Cats - Calming Supplement , by Region USD Million (2017-2022)
  • Table 8. Stress/Anxiety Treatment for Dogs & Cats - Product (Diffusers, Collars, and Humidifier) , by Region USD Million (2017-2022)
  • Table 9. Stress/Anxiety Treatment for Dogs & Cats Category , by Region USD Million (2017-2022)
  • Table 10. Stress/Anxiety Treatment for Dogs & Cats - Prescribe base , by Region USD Million (2017-2022)
  • Table 11. Stress/Anxiety Treatment for Dogs & Cats - OTC , by Region USD Million (2017-2022)
  • Table 12. Stress/Anxiety Treatment for Dogs & Cats Nature , by Region USD Million (2017-2022)
  • Table 13. Stress/Anxiety Treatment for Dogs & Cats - Branded , by Region USD Million (2017-2022)
  • Table 14. Stress/Anxiety Treatment for Dogs & Cats - Generics , by Region USD Million (2017-2022)
  • Table 15. Stress/Anxiety Treatment for Dogs & Cats Compound , by Region USD Million (2017-2022)
  • Table 16. Stress/Anxiety Treatment for Dogs & Cats - Nutraceuticals , by Region USD Million (2017-2022)
  • Table 17. Stress/Anxiety Treatment for Dogs & Cats - Pharmaceutical , by Region USD Million (2017-2022)
  • Table 18. Stress/Anxiety Treatment for Dogs & Cats - Bio Pharmaceutical , by Region USD Million (2017-2022)
  • Table 19. Stress/Anxiety Treatment for Dogs & Cats: by End User(USD Million)
  • Table 20. Stress/Anxiety Treatment for Dogs & Cats Cats , by Region USD Million (2017-2022)
  • Table 21. Stress/Anxiety Treatment for Dogs & Cats Dogs , by Region USD Million (2017-2022)
  • Table 22. South America Stress/Anxiety Treatment for Dogs & Cats, by Country USD Million (2017-2022)
  • Table 23. South America Stress/Anxiety Treatment for Dogs & Cats, by Sales Channel USD Million (2017-2022)
  • Table 24. South America Stress/Anxiety Treatment for Dogs & Cats, by Medication USD Million (2017-2022)
  • Table 25. South America Stress/Anxiety Treatment for Dogs & Cats, by End User USD Million (2017-2022)
  • Table 26. Brazil Stress/Anxiety Treatment for Dogs & Cats, by Sales Channel USD Million (2017-2022)
  • Table 27. Brazil Stress/Anxiety Treatment for Dogs & Cats, by Medication USD Million (2017-2022)
  • Table 28. Brazil Stress/Anxiety Treatment for Dogs & Cats, by End User USD Million (2017-2022)
  • Table 29. Argentina Stress/Anxiety Treatment for Dogs & Cats, by Sales Channel USD Million (2017-2022)
  • Table 30. Argentina Stress/Anxiety Treatment for Dogs & Cats, by Medication USD Million (2017-2022)
  • Table 31. Argentina Stress/Anxiety Treatment for Dogs & Cats, by End User USD Million (2017-2022)
  • Table 32. Rest of South America Stress/Anxiety Treatment for Dogs & Cats, by Sales Channel USD Million (2017-2022)
  • Table 33. Rest of South America Stress/Anxiety Treatment for Dogs & Cats, by Medication USD Million (2017-2022)
  • Table 34. Rest of South America Stress/Anxiety Treatment for Dogs & Cats, by End User USD Million (2017-2022)
  • Table 35. Asia Pacific Stress/Anxiety Treatment for Dogs & Cats, by Country USD Million (2017-2022)
  • Table 36. Asia Pacific Stress/Anxiety Treatment for Dogs & Cats, by Sales Channel USD Million (2017-2022)
  • Table 37. Asia Pacific Stress/Anxiety Treatment for Dogs & Cats, by Medication USD Million (2017-2022)
  • Table 38. Asia Pacific Stress/Anxiety Treatment for Dogs & Cats, by End User USD Million (2017-2022)
  • Table 39. China Stress/Anxiety Treatment for Dogs & Cats, by Sales Channel USD Million (2017-2022)
  • Table 40. China Stress/Anxiety Treatment for Dogs & Cats, by Medication USD Million (2017-2022)
  • Table 41. China Stress/Anxiety Treatment for Dogs & Cats, by End User USD Million (2017-2022)
  • Table 42. Japan Stress/Anxiety Treatment for Dogs & Cats, by Sales Channel USD Million (2017-2022)
  • Table 43. Japan Stress/Anxiety Treatment for Dogs & Cats, by Medication USD Million (2017-2022)
  • Table 44. Japan Stress/Anxiety Treatment for Dogs & Cats, by End User USD Million (2017-2022)
  • Table 45. India Stress/Anxiety Treatment for Dogs & Cats, by Sales Channel USD Million (2017-2022)
  • Table 46. India Stress/Anxiety Treatment for Dogs & Cats, by Medication USD Million (2017-2022)
  • Table 47. India Stress/Anxiety Treatment for Dogs & Cats, by End User USD Million (2017-2022)
  • Table 48. South Korea Stress/Anxiety Treatment for Dogs & Cats, by Sales Channel USD Million (2017-2022)
  • Table 49. South Korea Stress/Anxiety Treatment for Dogs & Cats, by Medication USD Million (2017-2022)
  • Table 50. South Korea Stress/Anxiety Treatment for Dogs & Cats, by End User USD Million (2017-2022)
  • Table 51. Taiwan Stress/Anxiety Treatment for Dogs & Cats, by Sales Channel USD Million (2017-2022)
  • Table 52. Taiwan Stress/Anxiety Treatment for Dogs & Cats, by Medication USD Million (2017-2022)
  • Table 53. Taiwan Stress/Anxiety Treatment for Dogs & Cats, by End User USD Million (2017-2022)
  • Table 54. Australia Stress/Anxiety Treatment for Dogs & Cats, by Sales Channel USD Million (2017-2022)
  • Table 55. Australia Stress/Anxiety Treatment for Dogs & Cats, by Medication USD Million (2017-2022)
  • Table 56. Australia Stress/Anxiety Treatment for Dogs & Cats, by End User USD Million (2017-2022)
  • Table 57. Rest of Asia-Pacific Stress/Anxiety Treatment for Dogs & Cats, by Sales Channel USD Million (2017-2022)
  • Table 58. Rest of Asia-Pacific Stress/Anxiety Treatment for Dogs & Cats, by Medication USD Million (2017-2022)
  • Table 59. Rest of Asia-Pacific Stress/Anxiety Treatment for Dogs & Cats, by End User USD Million (2017-2022)
  • Table 60. Europe Stress/Anxiety Treatment for Dogs & Cats, by Country USD Million (2017-2022)
  • Table 61. Europe Stress/Anxiety Treatment for Dogs & Cats, by Sales Channel USD Million (2017-2022)
  • Table 62. Europe Stress/Anxiety Treatment for Dogs & Cats, by Medication USD Million (2017-2022)
  • Table 63. Europe Stress/Anxiety Treatment for Dogs & Cats, by End User USD Million (2017-2022)
  • Table 64. Germany Stress/Anxiety Treatment for Dogs & Cats, by Sales Channel USD Million (2017-2022)
  • Table 65. Germany Stress/Anxiety Treatment for Dogs & Cats, by Medication USD Million (2017-2022)
  • Table 66. Germany Stress/Anxiety Treatment for Dogs & Cats, by End User USD Million (2017-2022)
  • Table 67. France Stress/Anxiety Treatment for Dogs & Cats, by Sales Channel USD Million (2017-2022)
  • Table 68. France Stress/Anxiety Treatment for Dogs & Cats, by Medication USD Million (2017-2022)
  • Table 69. France Stress/Anxiety Treatment for Dogs & Cats, by End User USD Million (2017-2022)
  • Table 70. Italy Stress/Anxiety Treatment for Dogs & Cats, by Sales Channel USD Million (2017-2022)
  • Table 71. Italy Stress/Anxiety Treatment for Dogs & Cats, by Medication USD Million (2017-2022)
  • Table 72. Italy Stress/Anxiety Treatment for Dogs & Cats, by End User USD Million (2017-2022)
  • Table 73. United Kingdom Stress/Anxiety Treatment for Dogs & Cats, by Sales Channel USD Million (2017-2022)
  • Table 74. United Kingdom Stress/Anxiety Treatment for Dogs & Cats, by Medication USD Million (2017-2022)
  • Table 75. United Kingdom Stress/Anxiety Treatment for Dogs & Cats, by End User USD Million (2017-2022)
  • Table 76. Netherlands Stress/Anxiety Treatment for Dogs & Cats, by Sales Channel USD Million (2017-2022)
  • Table 77. Netherlands Stress/Anxiety Treatment for Dogs & Cats, by Medication USD Million (2017-2022)
  • Table 78. Netherlands Stress/Anxiety Treatment for Dogs & Cats, by End User USD Million (2017-2022)
  • Table 79. Rest of Europe Stress/Anxiety Treatment for Dogs & Cats, by Sales Channel USD Million (2017-2022)
  • Table 80. Rest of Europe Stress/Anxiety Treatment for Dogs & Cats, by Medication USD Million (2017-2022)
  • Table 81. Rest of Europe Stress/Anxiety Treatment for Dogs & Cats, by End User USD Million (2017-2022)
  • Table 82. MEA Stress/Anxiety Treatment for Dogs & Cats, by Country USD Million (2017-2022)
  • Table 83. MEA Stress/Anxiety Treatment for Dogs & Cats, by Sales Channel USD Million (2017-2022)
  • Table 84. MEA Stress/Anxiety Treatment for Dogs & Cats, by Medication USD Million (2017-2022)
  • Table 85. MEA Stress/Anxiety Treatment for Dogs & Cats, by End User USD Million (2017-2022)
  • Table 86. Middle East Stress/Anxiety Treatment for Dogs & Cats, by Sales Channel USD Million (2017-2022)
  • Table 87. Middle East Stress/Anxiety Treatment for Dogs & Cats, by Medication USD Million (2017-2022)
  • Table 88. Middle East Stress/Anxiety Treatment for Dogs & Cats, by End User USD Million (2017-2022)
  • Table 89. Africa Stress/Anxiety Treatment for Dogs & Cats, by Sales Channel USD Million (2017-2022)
  • Table 90. Africa Stress/Anxiety Treatment for Dogs & Cats, by Medication USD Million (2017-2022)
  • Table 91. Africa Stress/Anxiety Treatment for Dogs & Cats, by End User USD Million (2017-2022)
  • Table 92. North America Stress/Anxiety Treatment for Dogs & Cats, by Country USD Million (2017-2022)
  • Table 93. North America Stress/Anxiety Treatment for Dogs & Cats, by Sales Channel USD Million (2017-2022)
  • Table 94. North America Stress/Anxiety Treatment for Dogs & Cats, by Medication USD Million (2017-2022)
  • Table 95. North America Stress/Anxiety Treatment for Dogs & Cats, by End User USD Million (2017-2022)
  • Table 96. United States Stress/Anxiety Treatment for Dogs & Cats, by Sales Channel USD Million (2017-2022)
  • Table 97. United States Stress/Anxiety Treatment for Dogs & Cats, by Medication USD Million (2017-2022)
  • Table 98. United States Stress/Anxiety Treatment for Dogs & Cats, by End User USD Million (2017-2022)
  • Table 99. Canada Stress/Anxiety Treatment for Dogs & Cats, by Sales Channel USD Million (2017-2022)
  • Table 100. Canada Stress/Anxiety Treatment for Dogs & Cats, by Medication USD Million (2017-2022)
  • Table 101. Canada Stress/Anxiety Treatment for Dogs & Cats, by End User USD Million (2017-2022)
  • Table 102. Mexico Stress/Anxiety Treatment for Dogs & Cats, by Sales Channel USD Million (2017-2022)
  • Table 103. Mexico Stress/Anxiety Treatment for Dogs & Cats, by Medication USD Million (2017-2022)
  • Table 104. Mexico Stress/Anxiety Treatment for Dogs & Cats, by End User USD Million (2017-2022)
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Company Basic Information, Sales Area and Its Competitors
  • Table 112. Company Basic Information, Sales Area and Its Competitors
  • Table 113. Company Basic Information, Sales Area and Its Competitors
  • Table 114. Company Basic Information, Sales Area and Its Competitors
  • Table 115. Stress/Anxiety Treatment for Dogs & Cats: by Sales Channel(USD Million)
  • Table 116. Stress/Anxiety Treatment for Dogs & Cats Offline (Vets, Retail) , by Region USD Million (2023-2028)
  • Table 117. Stress/Anxiety Treatment for Dogs & Cats Online , by Region USD Million (2023-2028)
  • Table 118. Stress/Anxiety Treatment for Dogs & Cats: by Medication(USD Million)
  • Table 119. Stress/Anxiety Treatment for Dogs & Cats Product Category , by Region USD Million (2023-2028)
  • Table 120. Stress/Anxiety Treatment for Dogs & Cats - Drug (Diazepam, Sileo, Clomicalm, fluoxetine, Paroxetine, Sertraline other) , by Region USD Million (2023-2028)
  • Table 121. Stress/Anxiety Treatment for Dogs & Cats - Calming Supplement , by Region USD Million (2023-2028)
  • Table 122. Stress/Anxiety Treatment for Dogs & Cats - Product (Diffusers, Collars, and Humidifier) , by Region USD Million (2023-2028)
  • Table 123. Stress/Anxiety Treatment for Dogs & Cats Category , by Region USD Million (2023-2028)
  • Table 124. Stress/Anxiety Treatment for Dogs & Cats - Prescribe base , by Region USD Million (2023-2028)
  • Table 125. Stress/Anxiety Treatment for Dogs & Cats - OTC , by Region USD Million (2023-2028)
  • Table 126. Stress/Anxiety Treatment for Dogs & Cats Nature , by Region USD Million (2023-2028)
  • Table 127. Stress/Anxiety Treatment for Dogs & Cats - Branded , by Region USD Million (2023-2028)
  • Table 128. Stress/Anxiety Treatment for Dogs & Cats - Generics , by Region USD Million (2023-2028)
  • Table 129. Stress/Anxiety Treatment for Dogs & Cats Compound , by Region USD Million (2023-2028)
  • Table 130. Stress/Anxiety Treatment for Dogs & Cats - Nutraceuticals , by Region USD Million (2023-2028)
  • Table 131. Stress/Anxiety Treatment for Dogs & Cats - Pharmaceutical , by Region USD Million (2023-2028)
  • Table 132. Stress/Anxiety Treatment for Dogs & Cats - Bio Pharmaceutical , by Region USD Million (2023-2028)
  • Table 133. Stress/Anxiety Treatment for Dogs & Cats: by End User(USD Million)
  • Table 134. Stress/Anxiety Treatment for Dogs & Cats Cats , by Region USD Million (2023-2028)
  • Table 135. Stress/Anxiety Treatment for Dogs & Cats Dogs , by Region USD Million (2023-2028)
  • Table 136. South America Stress/Anxiety Treatment for Dogs & Cats, by Country USD Million (2023-2028)
  • Table 137. South America Stress/Anxiety Treatment for Dogs & Cats, by Sales Channel USD Million (2023-2028)
  • Table 138. South America Stress/Anxiety Treatment for Dogs & Cats, by Medication USD Million (2023-2028)
  • Table 139. South America Stress/Anxiety Treatment for Dogs & Cats, by End User USD Million (2023-2028)
  • Table 140. Brazil Stress/Anxiety Treatment for Dogs & Cats, by Sales Channel USD Million (2023-2028)
  • Table 141. Brazil Stress/Anxiety Treatment for Dogs & Cats, by Medication USD Million (2023-2028)
  • Table 142. Brazil Stress/Anxiety Treatment for Dogs & Cats, by End User USD Million (2023-2028)
  • Table 143. Argentina Stress/Anxiety Treatment for Dogs & Cats, by Sales Channel USD Million (2023-2028)
  • Table 144. Argentina Stress/Anxiety Treatment for Dogs & Cats, by Medication USD Million (2023-2028)
  • Table 145. Argentina Stress/Anxiety Treatment for Dogs & Cats, by End User USD Million (2023-2028)
  • Table 146. Rest of South America Stress/Anxiety Treatment for Dogs & Cats, by Sales Channel USD Million (2023-2028)
  • Table 147. Rest of South America Stress/Anxiety Treatment for Dogs & Cats, by Medication USD Million (2023-2028)
  • Table 148. Rest of South America Stress/Anxiety Treatment for Dogs & Cats, by End User USD Million (2023-2028)
  • Table 149. Asia Pacific Stress/Anxiety Treatment for Dogs & Cats, by Country USD Million (2023-2028)
  • Table 150. Asia Pacific Stress/Anxiety Treatment for Dogs & Cats, by Sales Channel USD Million (2023-2028)
  • Table 151. Asia Pacific Stress/Anxiety Treatment for Dogs & Cats, by Medication USD Million (2023-2028)
  • Table 152. Asia Pacific Stress/Anxiety Treatment for Dogs & Cats, by End User USD Million (2023-2028)
  • Table 153. China Stress/Anxiety Treatment for Dogs & Cats, by Sales Channel USD Million (2023-2028)
  • Table 154. China Stress/Anxiety Treatment for Dogs & Cats, by Medication USD Million (2023-2028)
  • Table 155. China Stress/Anxiety Treatment for Dogs & Cats, by End User USD Million (2023-2028)
  • Table 156. Japan Stress/Anxiety Treatment for Dogs & Cats, by Sales Channel USD Million (2023-2028)
  • Table 157. Japan Stress/Anxiety Treatment for Dogs & Cats, by Medication USD Million (2023-2028)
  • Table 158. Japan Stress/Anxiety Treatment for Dogs & Cats, by End User USD Million (2023-2028)
  • Table 159. India Stress/Anxiety Treatment for Dogs & Cats, by Sales Channel USD Million (2023-2028)
  • Table 160. India Stress/Anxiety Treatment for Dogs & Cats, by Medication USD Million (2023-2028)
  • Table 161. India Stress/Anxiety Treatment for Dogs & Cats, by End User USD Million (2023-2028)
  • Table 162. South Korea Stress/Anxiety Treatment for Dogs & Cats, by Sales Channel USD Million (2023-2028)
  • Table 163. South Korea Stress/Anxiety Treatment for Dogs & Cats, by Medication USD Million (2023-2028)
  • Table 164. South Korea Stress/Anxiety Treatment for Dogs & Cats, by End User USD Million (2023-2028)
  • Table 165. Taiwan Stress/Anxiety Treatment for Dogs & Cats, by Sales Channel USD Million (2023-2028)
  • Table 166. Taiwan Stress/Anxiety Treatment for Dogs & Cats, by Medication USD Million (2023-2028)
  • Table 167. Taiwan Stress/Anxiety Treatment for Dogs & Cats, by End User USD Million (2023-2028)
  • Table 168. Australia Stress/Anxiety Treatment for Dogs & Cats, by Sales Channel USD Million (2023-2028)
  • Table 169. Australia Stress/Anxiety Treatment for Dogs & Cats, by Medication USD Million (2023-2028)
  • Table 170. Australia Stress/Anxiety Treatment for Dogs & Cats, by End User USD Million (2023-2028)
  • Table 171. Rest of Asia-Pacific Stress/Anxiety Treatment for Dogs & Cats, by Sales Channel USD Million (2023-2028)
  • Table 172. Rest of Asia-Pacific Stress/Anxiety Treatment for Dogs & Cats, by Medication USD Million (2023-2028)
  • Table 173. Rest of Asia-Pacific Stress/Anxiety Treatment for Dogs & Cats, by End User USD Million (2023-2028)
  • Table 174. Europe Stress/Anxiety Treatment for Dogs & Cats, by Country USD Million (2023-2028)
  • Table 175. Europe Stress/Anxiety Treatment for Dogs & Cats, by Sales Channel USD Million (2023-2028)
  • Table 176. Europe Stress/Anxiety Treatment for Dogs & Cats, by Medication USD Million (2023-2028)
  • Table 177. Europe Stress/Anxiety Treatment for Dogs & Cats, by End User USD Million (2023-2028)
  • Table 178. Germany Stress/Anxiety Treatment for Dogs & Cats, by Sales Channel USD Million (2023-2028)
  • Table 179. Germany Stress/Anxiety Treatment for Dogs & Cats, by Medication USD Million (2023-2028)
  • Table 180. Germany Stress/Anxiety Treatment for Dogs & Cats, by End User USD Million (2023-2028)
  • Table 181. France Stress/Anxiety Treatment for Dogs & Cats, by Sales Channel USD Million (2023-2028)
  • Table 182. France Stress/Anxiety Treatment for Dogs & Cats, by Medication USD Million (2023-2028)
  • Table 183. France Stress/Anxiety Treatment for Dogs & Cats, by End User USD Million (2023-2028)
  • Table 184. Italy Stress/Anxiety Treatment for Dogs & Cats, by Sales Channel USD Million (2023-2028)
  • Table 185. Italy Stress/Anxiety Treatment for Dogs & Cats, by Medication USD Million (2023-2028)
  • Table 186. Italy Stress/Anxiety Treatment for Dogs & Cats, by End User USD Million (2023-2028)
  • Table 187. United Kingdom Stress/Anxiety Treatment for Dogs & Cats, by Sales Channel USD Million (2023-2028)
  • Table 188. United Kingdom Stress/Anxiety Treatment for Dogs & Cats, by Medication USD Million (2023-2028)
  • Table 189. United Kingdom Stress/Anxiety Treatment for Dogs & Cats, by End User USD Million (2023-2028)
  • Table 190. Netherlands Stress/Anxiety Treatment for Dogs & Cats, by Sales Channel USD Million (2023-2028)
  • Table 191. Netherlands Stress/Anxiety Treatment for Dogs & Cats, by Medication USD Million (2023-2028)
  • Table 192. Netherlands Stress/Anxiety Treatment for Dogs & Cats, by End User USD Million (2023-2028)
  • Table 193. Rest of Europe Stress/Anxiety Treatment for Dogs & Cats, by Sales Channel USD Million (2023-2028)
  • Table 194. Rest of Europe Stress/Anxiety Treatment for Dogs & Cats, by Medication USD Million (2023-2028)
  • Table 195. Rest of Europe Stress/Anxiety Treatment for Dogs & Cats, by End User USD Million (2023-2028)
  • Table 196. MEA Stress/Anxiety Treatment for Dogs & Cats, by Country USD Million (2023-2028)
  • Table 197. MEA Stress/Anxiety Treatment for Dogs & Cats, by Sales Channel USD Million (2023-2028)
  • Table 198. MEA Stress/Anxiety Treatment for Dogs & Cats, by Medication USD Million (2023-2028)
  • Table 199. MEA Stress/Anxiety Treatment for Dogs & Cats, by End User USD Million (2023-2028)
  • Table 200. Middle East Stress/Anxiety Treatment for Dogs & Cats, by Sales Channel USD Million (2023-2028)
  • Table 201. Middle East Stress/Anxiety Treatment for Dogs & Cats, by Medication USD Million (2023-2028)
  • Table 202. Middle East Stress/Anxiety Treatment for Dogs & Cats, by End User USD Million (2023-2028)
  • Table 203. Africa Stress/Anxiety Treatment for Dogs & Cats, by Sales Channel USD Million (2023-2028)
  • Table 204. Africa Stress/Anxiety Treatment for Dogs & Cats, by Medication USD Million (2023-2028)
  • Table 205. Africa Stress/Anxiety Treatment for Dogs & Cats, by End User USD Million (2023-2028)
  • Table 206. North America Stress/Anxiety Treatment for Dogs & Cats, by Country USD Million (2023-2028)
  • Table 207. North America Stress/Anxiety Treatment for Dogs & Cats, by Sales Channel USD Million (2023-2028)
  • Table 208. North America Stress/Anxiety Treatment for Dogs & Cats, by Medication USD Million (2023-2028)
  • Table 209. North America Stress/Anxiety Treatment for Dogs & Cats, by End User USD Million (2023-2028)
  • Table 210. United States Stress/Anxiety Treatment for Dogs & Cats, by Sales Channel USD Million (2023-2028)
  • Table 211. United States Stress/Anxiety Treatment for Dogs & Cats, by Medication USD Million (2023-2028)
  • Table 212. United States Stress/Anxiety Treatment for Dogs & Cats, by End User USD Million (2023-2028)
  • Table 213. Canada Stress/Anxiety Treatment for Dogs & Cats, by Sales Channel USD Million (2023-2028)
  • Table 214. Canada Stress/Anxiety Treatment for Dogs & Cats, by Medication USD Million (2023-2028)
  • Table 215. Canada Stress/Anxiety Treatment for Dogs & Cats, by End User USD Million (2023-2028)
  • Table 216. Mexico Stress/Anxiety Treatment for Dogs & Cats, by Sales Channel USD Million (2023-2028)
  • Table 217. Mexico Stress/Anxiety Treatment for Dogs & Cats, by Medication USD Million (2023-2028)
  • Table 218. Mexico Stress/Anxiety Treatment for Dogs & Cats, by End User USD Million (2023-2028)
  • Table 219. Research Programs/Design for This Report
  • Table 220. Key Data Information from Secondary Sources
  • Table 221. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Stress/Anxiety Treatment for Dogs & Cats: by Sales Channel USD Million (2017-2022)
  • Figure 5. Global Stress/Anxiety Treatment for Dogs & Cats: by Medication USD Million (2017-2022)
  • Figure 6. Global Stress/Anxiety Treatment for Dogs & Cats: by End User USD Million (2017-2022)
  • Figure 7. South America Stress/Anxiety Treatment for Dogs & Cats Share (%), by Country
  • Figure 8. Asia Pacific Stress/Anxiety Treatment for Dogs & Cats Share (%), by Country
  • Figure 9. Europe Stress/Anxiety Treatment for Dogs & Cats Share (%), by Country
  • Figure 10. MEA Stress/Anxiety Treatment for Dogs & Cats Share (%), by Country
  • Figure 11. North America Stress/Anxiety Treatment for Dogs & Cats Share (%), by Country
  • Figure 12. Global Stress/Anxiety Treatment for Dogs & Cats share by Players 2022 (%)
  • Figure 13. Global Stress/Anxiety Treatment for Dogs & Cats share by Players (Top 3) 2022(%)
  • Figure 14. Global Stress/Anxiety Treatment for Dogs & Cats share by Players (Top 5) 2022(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Vétoquinol S.A (France) Revenue, Net Income and Gross profit
  • Figure 17. Vétoquinol S.A (France) Revenue: by Geography 2022
  • Figure 18. SeQuent Scientific Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 19. SeQuent Scientific Ltd. (India) Revenue: by Geography 2022
  • Figure 20. Ceva Santé Animale (France) Revenue, Net Income and Gross profit
  • Figure 21. Ceva Santé Animale (France) Revenue: by Geography 2022
  • Figure 22. Elanco Animal Health (United States) Revenue, Net Income and Gross profit
  • Figure 23. Elanco Animal Health (United States) Revenue: by Geography 2022
  • Figure 24. Merck & Co., Inc (United States) Revenue, Net Income and Gross profit
  • Figure 25. Merck & Co., Inc (United States) Revenue: by Geography 2022
  • Figure 26. Nutreco N.V. (Netherlands) Revenue, Net Income and Gross profit
  • Figure 27. Nutreco N.V. (Netherlands) Revenue: by Geography 2022
  • Figure 28. Sanofi S.A (France) Revenue, Net Income and Gross profit
  • Figure 29. Sanofi S.A (France) Revenue: by Geography 2022
  • Figure 30. Zoetis Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 31. Zoetis Inc. (United States) Revenue: by Geography 2022
  • Figure 32. IDVet (France) Revenue, Net Income and Gross profit
  • Figure 33. IDVet (France) Revenue: by Geography 2022
  • Figure 34. Cargill, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 35. Cargill, Inc. (United States) Revenue: by Geography 2022
  • Figure 36. Global Stress/Anxiety Treatment for Dogs & Cats: by Sales Channel USD Million (2023-2028)
  • Figure 37. Global Stress/Anxiety Treatment for Dogs & Cats: by Medication USD Million (2023-2028)
  • Figure 38. Global Stress/Anxiety Treatment for Dogs & Cats: by End User USD Million (2023-2028)
  • Figure 39. South America Stress/Anxiety Treatment for Dogs & Cats Share (%), by Country
  • Figure 40. Asia Pacific Stress/Anxiety Treatment for Dogs & Cats Share (%), by Country
  • Figure 41. Europe Stress/Anxiety Treatment for Dogs & Cats Share (%), by Country
  • Figure 42. MEA Stress/Anxiety Treatment for Dogs & Cats Share (%), by Country
  • Figure 43. North America Stress/Anxiety Treatment for Dogs & Cats Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Vétoquinol S.A (France)
  • SeQuent Scientific Ltd. (India)
  • Ceva Santé Animale (France)
  • Elanco Animal Health (United States)
  • Merck & Co., Inc (United States)
  • Nutreco N.V. (Netherlands)
  • Sanofi S.A (France)
  • Zoetis Inc. (United States)
  • IDVet (France)
  • Cargill, Inc. (United States)
Additional players considered in the study are as follows:
Virbac (France) , DSM N.V (Netherlands) , Eli Lilly and Company (United States) , IDEXX Laboratories, Inc. (United States) , Canopy Growth (Canada)
Select User Access Type

Key Highlights of Report


Jun 2023 201 Pages 78 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Stress/Anxiety Treatment for Dogs & Cats Market Quantitative research analysis
Global Stress/Anxiety Treatment for Dogs & Cats Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Due to pricing constraints we only profile limited players in the study that includes a mix list of leaders and emerging players, however for evaluation of market size the coverage includes 100+ players.
Yes, the study does represent market size by key business segment, application/end users and major geographies forecasted till 2028
The Study can be customized to meet your requirements. Please connect with our representative, in case you wish to add or remove certain country or profiled players.
  • The Negative Impact of the COVID 19

Know More About Global Stress/Anxiety Treatment for Dogs & Cats Market Report?

Have a Query? Click Here

Other Related Reports

Flect Ct Imaging Comprehensive Study by Application (Oncology, Immunology, Cell Trafficking - NirFP, Drug Delivery, Cardiovascular Research, Neuroscience, Others), End Users (Clinical Research labora...
$ 3650
Pet Eye Cleaners Comprehensive Study by Type (Liquid Drops, Location, Eye Wipes, Eye Gel), Animals (Dogs, Cat, Birds, Other), Infection (Allergies, Birth defects, Tear duct issues, Injuries, Dry eye...
$ 3750
Medical Supply Delivery Service Comprehensive Study by Application (Medical Supply Delivery, Hospital Delivery, Specimen Transportation, Radioactive Materials, Surgical Deliveries, Others), Platforms...
$ 3650
Operating Theatre Management Tools Comprehensive Study by Solutions (Anaesthesia Information Management Systems, Data Management and Communication Solutions, Operating Room Supply Management Solution...
$ 3800
Healthcare Discount Plan Comprehensive Study by Type (Individual, Family), Application (Prescription Drugs, Virtual Visits, Vision Care, Dental Care, Alternative Care, Hearing Aids, Long-Term Care Se...
$ 3500
Functional Service Provider Comprehensive Study by Services (Pharmacovigilance, Medical Writing, Statistical Programming, Site Management, Regulatory Affairs, Regulatory Operations, Biostatistics, Ot...
$ 3500